Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain, Postoperative × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Neoplasms 26 Depression 20 Fatigue 18 Prostatic Neoplasms 13 Lymphoma, Follicular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Multiple Myeloma 11 Lymphoma, Large B-Cell, Diffuse 10 Lung Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Pain 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Hodgkin Disease 9 Colorectal Neoplasms 9 Burkitt Lymphoma 9 Anxiety Disorders 8 Vomiting 7 Nausea 7 Leukemia, Myeloid, Acute 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia, Hairy Cell 7 Head and Neck Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Blast Crisis 7

Interventions

Bupivacaine 18 Ropivacaine 10 Saline Solution 9 Dexmedetomidine 9 Sodium Chloride 5 Pregabalin 5 Morphine 5 Ketamine 5 Lidocaine 4 Dexamethasone 4 Control Groups 4 Analgesia, Patient-Controlled 4 Tea 3 Gabapentin 3 Anesthetics, Local 3 Acetaminophen 3 Population Groups 2 Parapsychology 2 Magnesium Sulfate 2 Injections, Epidural 2 Fentanyl 2 Dental Occlusion 2 Anti-Inflammatory Agents, Non-Steroidal 2 Analgesics, Opioid 2 thiamine triphosphorate 1 ramosetron 1 parecoxib 1 gamma-Aminobutyric Acid 1 esmolol 1 Water 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04518085 2023-12-08

PREVENT

University of Oslo

Phase NA Completed

Data powered by HemOnc (CC BY 4.0) Colophon ⚡